Identification of the interaction between the human recombinant histamine releasing factor/translationally controlled tumor protein and elongation factor-1 delta (also known as eElongation factor-1B beta)
- 10 January 2004
- journal article
- Published by Elsevier in Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease
- Vol. 1688 (3) , 232-236
- https://doi.org/10.1016/j.bbadis.2003.12.007
Abstract
No abstract availableKeywords
This publication has 36 references indexed in Scilit:
- Stimulation of human bronchial epithelial cells by IgE-dependent histamine-releasing factorAmerican Journal of Physiology-Lung Cellular and Molecular Physiology, 2004
- Mapping the human translation elongation factor eEF1H complex using the yeast two-hybrid systemBiochemical Journal, 2002
- Oncogenic Potential of Mouse Translation Elongation Factor-1δ, a Novel Cadmium-responsive Proto-oncogeneJournal of Biological Chemistry, 2002
- Identification of novel proteins associated with the development of chemoresistance in malignant melanoma using two-dimensional electrophoresisElectrophoresis, 2000
- Two‐dimensional gel electrophoresis of Caenorhabditis elegans homogenates and identification of protein spots by microsequencingElectrophoresis, 1997
- An immunoglobulin E-dependent recombinant histamine-releasing factor induces interleukin-4 secretion from human basophils.The Journal of Experimental Medicine, 1996
- Purification of novel calcium binding proteins from Trypanosoma brucei: properties of 22-, 24- and 38-kilodalton proteinsMolecular and Biochemical Parasitology, 1992
- The accuracy of aminoacylation — ensuring the fidelity of the genetic codeCellular and Molecular Life Sciences, 1990
- Eukaryotic protein elongation factorsTrends in Biochemical Sciences, 1990
- EFTu provides an internal kinetic standard for translational accuracyTrends in Biochemical Sciences, 1988